FY2026 Earnings Forecast for FDMT Issued By Leerink Partnrs
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) – Equities research analysts at Leerink Partnrs issued their FY2026 earnings estimates for shares of 4D Molecular Therapeutics in a research note issued on Wednesday, April 16th. Leerink Partnrs analyst M. Foroohar expects that the company will earn ($3.82) per share for the year. The consensus estimate […]
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) – Equities research analysts at Leerink Partnrs issued their FY2026 earnings estimates for shares of 4D Molecular Therapeutics in a research note issued on Wednesday, April 16th. Leerink Partnrs analyst M. Foroohar expects that the company will earn ($3.82) per share for the year. The consensus estimate […]
